BOT botanix pharmaceuticals ltd

Ann: Botanix Provides Sofdra Launch Update, page-461

  1. 866 Posts.
    lightbulb Created with Sketch. 258
    2b Shares

    FY 26 Revenue expected $100m
    EV/Revenue Multiple of x10

    $1bil valuation over shares on issue

    Still gives us a conservative 50cent share price in 12 months

    From CMP the upside is more than 100%

    Lot went wrong but its still selling and a scaling derma product. Give it 12 months to get a good uptake in the market.

    In for the long haul.

    I get it plenty have lost money. Im still down but not far off. Could've been worse.

    Held this long and still my numbers and valuation is unchanged.

    Conservative by nature and my valuation and estimates as rough as they were, were not ridiculously extend like others here.

    This is not for newbies or the feint hearted, the long runway, aggressive forecasts, and product execution requirements mean there's meaningful downside if anything falters yet again, that's what we saw. Coupled with short action, panic selling

    it was just the whole recipe needed for a massive drop.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.5¢
Change
-0.005(3.33%)
Mkt cap ! $284.3M
Open High Low Value Volume
15.0¢ 15.3¢ 14.0¢ $2.762M 18.84M

Buyers (Bids)

No. Vol. Price($)
26 858705 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 1328637 14
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.